company background image

iCAD NasdaqCM:ICAD Stock Report

Last Price


Market Cap







02 Oct, 2022


Company Financials +
ICAD fundamental analysis
Snowflake Score
Future Growth5/6
Past Performance0/6
Financial Health6/6

ICAD Stock Overview

iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States.

iCAD, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for iCAD
Historical stock prices
Current Share PriceUS$2.10
52 Week HighUS$11.79
52 Week LowUS$1.97
1 Month Change-29.29%
3 Month Change-46.84%
1 Year Change-80.48%
3 Year Change-68.84%
5 Year Change-54.25%
Change since IPO-95.85%

Recent News & Updates

Shareholder Returns

ICADUS Healthcare ServicesUS Market

Return vs Industry: ICAD underperformed the US Healthcare Services industry which returned -54.2% over the past year.

Return vs Market: ICAD underperformed the US Market which returned -23.2% over the past year.

Price Volatility

Is ICAD's price volatile compared to industry and market?
ICAD volatility
ICAD Average Weekly Movement9.0%
Healthcare Services Industry Average Movement10.3%
Market Average Movement6.8%
10% most volatile stocks in US Market15.5%
10% least volatile stocks in US Market2.8%

Stable Share Price: ICAD is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 9% a week.

Volatility Over Time: ICAD's weekly volatility (9%) has been stable over the past year.

About the Company

1984137Stacey Stevens

iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, and image storage and review systems; SecondLook, a machine learning-based cancer detection algorithm that analyzes 2D full-field digital mammography images to identify and mark suspicious masses and calcifications; and automated density assessment solutions, which provides automated, consistent, and standardized density assessment.

iCAD, Inc. Fundamentals Summary

How do iCAD's earnings and revenue compare to its market cap?
ICAD fundamental statistics
Market CapUS$53.20m
Earnings (TTM)-US$12.98m
Revenue (TTM)US$32.27m


P/S Ratio


P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
ICAD income statement (TTM)
Cost of RevenueUS$8.74m
Gross ProfitUS$23.53m
Other ExpensesUS$36.51m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date


Earnings per share (EPS)-0.51
Gross Margin72.92%
Net Profit Margin-40.24%
Debt/Equity Ratio0%

How did ICAD perform over the long term?

See historical performance and comparison